USANA Health Sciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.0% | -32.0% | -54.8% | +269.6% | -80.4% | +167.6% | -21.1% | -116.1% | – | – | +138.9% | – | |
| – | -5.6% | +4.4% | +12.2% | -2.5% | +5.8% | +74.1% | -6.3% | -0.4% | +7.5% | -4.8% | -21.6% | – | |
| – | -0.7% | +0.7% | +1.8% | -5.1% | +2.0% | -20.3% | +25.8% | -1.3% | +4.9% | -7.9% | -1.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -185.0% | – | – | – | -164.0% | – | – | – | – | – | – | – | |
| – | +403.7% | -56.3% | -16.6% | -10.2% | -24.9% | +55.5% | +79.3% | -36.4% | -12.6% | -5.4% | +19.3% | – | |
| – | +403.6% | -44.4% | -62.0% | +51.2% | +8,674.1% | -98.1% | +7.4% | -23.2% | – | -334.0% | +56.2% | – | |
| – | -98.8% | +6,947.8% | -99.7% | +154.8% | -6.3% | +16,521.6% | +23.6% | -100.0% | – | – | – | – | |
| – | – | – | – | – | +2,300,300.0% | -100.0% | – | -100.0% | – | -100.0% | – | – | |
| – | – | -1,915.5% | -88.7% | -94.2% | – | -163.1% | +166.9% | -97.5% | – | -127.1% | +285.2% | – | |
| – | +240.4% | -109.1% | – | +700.3% | -662.7% | – | – | – | – | -66.6% | +33.9% | – | |
| – | -10.0% | -22.6% | -63.3% | +410.2% | -85.3% | +218.3% | -43.3% | -171.7% | – | – | +183.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.